Lecithin and Provera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lecithin (phosphatidylcholine) and Provera (medroxyprogesterone acetate). Common drug interactions include infusion site erythema among females.

The phase IV clinical study analyzes what interactions people have when they take Lecithin and Provera. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Lecithin?

Lecithin has active ingredients of phosphatidylcholine. It is often used in high blood cholesterol. eHealthMe is studying from 2,310 Lecithin users. Check the latest studies of Lecithin.

What is Provera?

Provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 54,943 Provera users. Check the latest studies of Provera.



On Jul, 13, 2026

19 people who take Lecithin and Provera together, and have interactions are studied.

Lecithin and Provera drug interactions.

What are the common drug interactions of Lecithin and Provera, by gender? *:

female:

  1. Infusion site erythema (reddening of the skin at infusion site)
  2. Infusion site pain
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Drug effect decreased
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Infusion site mass
  7. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  8. Joint injury
  9. Nausea (feeling of having an urge to vomit)
  10. Osteonecrosis of jaw (death of bone of jaw)

male:

n/a

What are the common drug interactions of Lecithin and Provera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Device dislocation
  2. Hyperhidrosis (abnormally increased sweating)
  3. Infusion site discomfort
  4. Infusion site erythema (reddening of the skin at infusion site)
  5. Infusion site induration
  6. Infusion site irritation
  7. Infusion site pain
  8. Infusion site pruritus (severe itching at infusion site)

40-49:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Depression
  3. Drug effect decreased
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Headache (pain in head)
  6. Intestinal obstruction
  7. Joint injury
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Muscle spasms (muscle contraction)
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Drug ineffective

60+:

  1. Abdominal pain
  2. Arthralgia (joint pain)
  3. Blood glucose increased
  4. Drug effect decreased
  5. Fatigue (feeling of tiredness)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Glycosylated haemoglobin increased
  8. Headache (pain in head)
  9. Joint injury
  10. Muscle spasms (muscle contraction)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 31.58%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 15.79%
  3. Pain: 3 people, 15.79%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.26%
  5. Depression: 1 person, 5.26%
  6. Drowsiness: 1 person, 5.26%
  7. Fat Intolerance (inability to use fat by digestive system): 1 person, 5.26%
  8. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 5.26%
  9. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 5.26%
  10. Hypersensitivity: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Lecithin and Provera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lecithin and Provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lecithin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lecithin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Provera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phosphatidylcholine and medroxyprogesterone acetate (the active ingredients of Lecithin and Provera, respectively), and Lecithin and Provera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: